In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine.
In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine. Patient files will be screened for relevant information. Individual patients can be included multiple times if vancomycin has been administered more than once.
Study Type
OBSERVATIONAL
Enrollment
368
Investigation of plasma exposure of vancomycin.
UZ Leuven
Leuven, Belgium
Loading dose related plasma exposure vancomycin
Plasma exposure to vancomycin in relation to administered dose
Time frame: 24 hours after loading dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.